EP Patent

EP3567038A1 — Process for the preparation of quinazolinyl derivatives

Assigned to Hetero Labs Ltd · Expires 2019-11-13 · 7y expired

What this patent protects

The present invention relates to processes for the preparation of afatinib base and afatinib dimaleate.

USPTO Abstract

The present invention relates to processes for the preparation of afatinib base and afatinib dimaleate.

Drugs covered by this patent

afatinib-dimaleate (AFATINIB DIMALEATE)

Patent Metadata

Patent number: EP3567038A1
Jurisdiction: EP
Classification: —
Expires: 2019-11-13
Drug substance claim: No
Drug product claim: No
Assignee: Hetero Labs Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.